ArticleHighlights in Diabetes and Metabolism From ASN 2022 Author:Carol Wysham, MDPublish date: November 28, 2022From ASN 2022, Dr Carol Wysham highlights data on glucose-lowering drugs in patients with T2D, including empagliflozin and semaglutide, and a link ...Read More
ArticleKey Data on Comorbidities in Type 2 Diabetes From EASD 2022Author:Carol Wysham, MDPublish date: October 6, 2022From EASD 2022, Dr Carol Wysham reports on advancing research for patients with type 2 diabetes and comorbidities, including nonalcoholic fatty liv...Read More